Completed
Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients
NCT00082498
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- UCLA CARE Center CRS Los Angeles, California, United States
- Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States
- UCSD Antiviral Research Center CRS San Diego, California, United States
- Ucsf Hiv/Aids Crs San Francisco, California, United States